1. Home
  2. Labeler Index
  3. Glaxosmithkline Llc
  4. 0173-0892
  5. NDC Package Code: 0173-0892-01 Nucala

NDC Package 0173-0892-01 Nucala

Mepolizumab Injection, Solution Subcutaneous - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
0173-0892-01
Package Description:
1 SYRINGE in 1 CARTON / 1 mL in 1 SYRINGE
Product Code:
0173-0892
Proprietary Name:
Nucala
Non-Proprietary Name:
Mepolizumab
Substance Name:
Mepolizumab
Usage Information:
This medication is used along with other medications to control and prevent symptoms (such as wheezing and shortness of breath) caused by asthma. Controlling symptoms of asthma helps you do your normal activities and decreases time lost from work or school. Mepolizumab works by reducing swelling (inflammation) of the airways in the lungs to make breathing easier. Mepolizumab is also used to treat a certain immune system diseases (eosinophilic granulomatosis with polyangiitis-EGPA, hypereosinophilic syndrome-HES). It helps to control and prevent symptoms (such as wheezing, shortness of breath, runny nose, facial pain, tiredness) caused by these diseases. It works by decreasing the amount of certain white blood cells (eosinophils) which may cause these diseases. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden asthma attacks or breathing problems. If an asthma attack occurs, use your quick-relief inhaler as prescribed.
11-Digit NDC Billing Format:
00173089201
Billing Unit:
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
NDC to RxNorm Crosswalk:
  • RxCUI: 1720601 - mepolizumab 100 MG Injection
  • RxCUI: 1720606 - Nucala 100 MG Injection
  • RxCUI: 1720606 - mepolizumab 100 MG Injection [Nucala]
  • RxCUI: 2170990 - mepolizumab 100 MG in 1 mL Auto-Injector
  • RxCUI: 2170990 - 1 ML mepolizumab 100 MG/ML Auto-Injector
    • Product Type:
    Human Prescription Drug
    Labeler Name:
    Glaxosmithkline Llc
    Dosage Form:
    Injection, Solution - A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection.
    Administration Route(s):
  • Subcutaneous - Administration beneath the skin; hypodermic. Synonymous with the term SUBDERMAL.
    • Active Ingredient(s):
  • MEPOLIZUMAB 100 mg/mL
    • Pharmacologic Class(es):
  • Interleukin-5 Antagonist - [EPC] (Established Pharmacologic Class)
  • Interleukin-5 Antagonists - [MoA] (Mechanism of Action)
    • Sample Package:
    No
    FDA Application Number:
    BLA761122
    Marketing Category:
    BLA - A product marketed under an approved Biologic License Application.
    Start Marketing Date:
    06-06-2019
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Other Product Packages

    The following packages are also available for this product:

    NDC Package CodePackage Description
    0173-0892-421 SYRINGE in 1 CARTON / 1 mL in 1 SYRINGE
    0173-0892-611 SYRINGE in 1 CARTON / 1 mL in 1 SYRINGE
    0173-0892-631 SYRINGE in 1 CARTON / 1 mL in 1 SYRINGE

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 0173-0892-01?

    The NDC Packaged Code 0173-0892-01 is assigned to a package of 1 syringe in 1 carton / 1 ml in 1 syringe of Nucala, a human prescription drug labeled by Glaxosmithkline Llc. The product's dosage form is injection, solution and is administered via subcutaneous form.

    Is NDC 0173-0892 included in the NDC Directory?

    Yes, Nucala with product code 0173-0892 is active and included in the NDC Directory. The product was first marketed by Glaxosmithkline Llc on June 06, 2019 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 0173-0892-01?

    The contents of this package are billed per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.

    What is the 11-digit format for NDC 0173-0892-01?

    The 11-digit format is 00173089201. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 4-4-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    4-4-20173-0892-015-4-200173-0892-01